Acupuncture for Taxane-induced Peripheral Neuropathy: A Randomized Controlled Trial
Anticancer Research · 2026-08 · 46 (8) · 4745-4753
DOI: 10.21873/anticanres.18331 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Anticancer Research, online erschienen am 29.07.2026. Verfasst von Satoshi Ohno und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Center, Shimane University Hospital, Shimane, Japan; ohno55@med.shimane-u.ac.jp. Hauptthemen laut MEDLINE: Peripheral Nervous System Diseases, Taxoids, Acupuncture Therapy, Antineoplastic Agents.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Research Center, Shimane University Hospital, Shimane, Japan; ohno55@med.shimane-u.ac.jp.
- Department of Rehabilitation Medicine, The University of Tokyo Hospital, Tokyo, Japan.
- Department of Acupuncture and Moxibustion, Niigata University Health and Welfare, Niigata, Japan.
- Department of Supportive Care, Saitama Medical University International Medical Center, Saitama, Japan.
- Department of Oriental Medicine, Saitama Medical University, Saitama, Japan.
Zitieren
APA
Ohno, S., Inokuchi, H., Kasuya, D., Takahashi, T., & Yamaguchi, S. (2026). Acupuncture for Taxane-induced Peripheral Neuropathy: A Randomized Controlled Trial. Anticancer Research, 46(8), 4745-4753. https://doi.org/10.21873/anticanres.18331
Vancouver
Ohno S, Inokuchi H, Kasuya D, Takahashi T, Yamaguchi S. Acupuncture for Taxane-induced Peripheral Neuropathy: A Randomized Controlled Trial. Anticancer Research. 2026;46(8):4745-4753. doi:10.21873/anticanres.18331
BibTeX
@article{Ohno2026,
author = {Ohno, Satoshi and Inokuchi, Haruhi and Kasuya, Daichi and Takahashi, Takao and Yamaguchi, Satoru},
title = {Acupuncture for Taxane-induced Peripheral Neuropathy: A Randomized Controlled Trial},
journal = {Anticancer Research},
year = {2026},
volume = {46},
number = {8},
pages = {4745--4753},
doi = {10.21873/anticanres.18331}
}
EUVIMED